LPAR6 and breast carcinoma: Interestingly, bioinformatics analyses of the two large datasets revealed that hallmark E2F, G2/M checkpoint, and myc target pathways were all significantly suppressed with regard to LPAR6 in breast cancer (Fig. 4a and b).